NCT03445871View on ClinicalTrials.gov

Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

May 28, 2020

Study Completion Date

May 28, 2020

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Blood sample

Blood samples will be collected for measuring PG-MTX blood concentration.

DIAGNOSTIC_TEST

CRQ

Compliance Rheumatology Questionnaire (CQR) is a self-administered questionnaire for to evaluate therapeutic observance during rheumatoid arthritis.

Trial Locations (1)

42100

Chu Saint Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT03445871 - Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate | Biotech Hunter | Biotech Hunter